Skip To Main Content

Cobimetinib

N/A

Lung

Phase III

A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (B-FAST)

NCT03178552

Phase II

A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (B-FAST)

NCT03178552

Solid Tumor

Phase I

HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors

NCT03284502

A Study to Evaluate the Safety, Tolerability, Processing by the Body and Effectiveness Against BRAF-mutated Solid Tumors or Melanoma of R07276389 by Itself or in Combination with Cobimetinib

ISRCTN13713551